Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

diabetes medication side effects Legal News Articles & Interviews

Ozempic MDL and Semaglutide Update

Ozempic MDL and Semaglutide Update March 15, 2024. By Jane Mundy.
Philadelphia, PA Fifty-five Ozempic and similar weight loss drug lawsuits have been centralized in Eastern Pennsylvania, with U.S. District Judge Gene E.K. Pratter at the helm of the MDL and scheduled to commence March 14 at the first status conference. The litigation claims that Novo Nordisk's Ozempic, Wegovy and Rybelsus and Eli Lilly's Mounjaro and Trulicity cause gastroparesis and other serious gastrointestinal injuries, and the companies failed to warn patients about the risks associated with GLP-1 receptor agonist medications.
Read [ Ozempic MDL and Semaglutide Update ]

Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim?

Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim? March 8, 2024. By Jane Mundy.
New York, NY As the demand for Ozempic and other semaglutide weight-loss drugs increases, more serious side effects such as stomach paralysis are being reported to medical professionals, the FDA, and attorneys.
Read [ Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim? ]

Weight Loss Drugmakers Face Stomach Paralysis Lawsuits

Weight Loss Drugmakers Face Stomach Paralysis Lawsuits January 27, 2024. By Jane Mundy.
Santa Clara, CA A drugmaker’s dream is a patient continuing treatment and forever refilling prescriptions--and that spells profit.  Such is the case with the weight loss drugs because discontinuing them leads to regaining lost weight. Ozempic, Mounjaro and Wegovy are star performers, but a drugmaker’s nightmare is the serious side effects that leads to lawsuits, particularly when the manufacturers failed to disclose potential long-term impacts of serious injuries such as gastroparesis.

Read [ Weight Loss Drugmakers Face Stomach Paralysis Lawsuits ]

Saxagliptin Heart Failure and Death Lawsuits Filed

Saxagliptin Heart Failure and Death Lawsuits Filed May 9, 2017. By Lucy Campbell.
Santa Clara, CA The diabetes drug saxagliptin is the subject of 14 lawsuits filed this week in New Jersey, alleging it raises the risk of heart failure. Lawyers for the plaintiffs estimate there are between 150 and 200 saxagliptin cases are pending nationwide, and may, ultimately, reach into the thousands. While most of the cases filed to date are brought by plaintiffs who have congestive heart failure or other cardiac symptoms, a handful of cases were brought on behalf of saxagliptin users who died.
Read [ Saxagliptin Heart Failure and Death Lawsuits Filed ]


Request Legal Help Now! - Free